Table 2 Characteristics of patients with NLNM
From: Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma
| Â | NLNM at initial surgery | NLNM at cancer recurrence | P |
|---|---|---|---|
(Group A) (n = 11) | (Group B) (n = 9) | ||
Age | 56.9 ± 11.3 | 64.0 ± 11.7 | 0.19 |
Parity | Â | Â | Â |
Nulliparous | 1 (9.1%) | 3 (33.3%) | 0.26 |
Histology | Â | Â | Â |
 Serous | 9 (81.8%) | 5 (55.6%) | 0.34 |
 Non-serous | 2 (18.2%) | 4 (44.4%) | |
Tumor size | Â | Â | Â |
 ≤6 cm | 3 (27.3%) | 3 (33.3%) | 1.00 |
 >6 cm | 8 (72.7%) | 6 (66.7%) | |
CA-125 at operation | Â | Â | Â |
 ≤35 | 0 | 1 (11.1%) | 0.35 |
 35–500 | 5 (45.5%) | 2 (22.2%) | |
 >500 | 6 (54.5%) | 6 (66.7%) | |
NLNM after initial surgery | |||
 <1 year |  | 2 (22.2%) |  |
 1–2 years | 4 (44.4%) | ||
 >2 years | 3 (33.3%) | ||
Lung or bone metastasis | 2 (18.2%) | 3* (33.3%) | 0.62 |
Brain metastasis | 1 (9.1%) | 4* (44.4%) | 0.13 |